AI in cancer market

1. Artificial Intelligence in Cancer Market Projected to Surpass USD 5,292.8 Billion by 2030| Fatpos Global Fatpos Global has released its comprehensive market analysis report titled “Artificial Intelligence in Cancer Market- Analysis of Market Size, Share & Trends for 2021 – 2030” The global artificial intelligence (AI) in cancer market is expected to experience remarkable growth, with projections indicating it will reach USD 5,292.8 billion by 2030. This surge represents a significant increase from USD 297.3 billion in 2020, with a compound annual growth rate (CAGR) of 34.4% over the forecast period from 2021 to 2030. This growth is fueled by the increasing application of AI in enhancing cancer diagnosis, treatment, and management. Request for Sample PDF: https://www.fatposglobal.com/sample-request/artificial-intelligence-in- the-cancer-market-842 Overview of AI in Cancer Treatment Artificial intelligence has become an integral part of daily life, influencing sectors such as media, transportation, and communications. In healthcare, AI is revolutionizing the way diseases are diagnosed and treated, particularly in oncology. With the increasing number of cancer diagnoses and the vast amount of data generated during treatment, AI's role in improving cancer care is of significant interest. AI assists medical professionals in retrieving critical information, interpreting medical images, and planning effective therapies, thereby streamlining the treatment process and enhancing patient outcomes. Market Highlights  Projected Growth: The AI in cancer market is expected to grow at a notable CAGR of 34.4% from 2021 to 2030. Key Drivers: The market's rapid expansion is driven by the rising influx of digital health data, a growing need to reduce healthcare costs, and an increasing demand for personalized medicine. The rising prevalence of chronic diseases, such as cancer, has further accelerated the need for early disease detection and tailored treatments, with AI playing a crucial role. Technological Advancements: Recent technological advancements, particularly in deep learning and natural language processing (NLP), are enabling more accurate predictions of illnesses based on patient history and improving the speed and accuracy of diagnoses.   Recent Developments in AI for Cancer Treatment  Digital Diagnostics Acquisition: In August 2020, Digital Diagnostics Inc., formerly known as IDx, acquired 3Derm Systems Inc. This acquisition aimed to enhance 3DermTriage's telemedicine capabilities in dermatology and prepare the AI-powered skin cancer diagnosis device, 3DermSpot, for FDA approval. GE Healthcare Collaborations: In September 2019, GE Healthcare partnered with five Chinese software companies—12Sigma Technologies, Shukun Technology, Biomind, YITU Technology, and Yizhun Medical AI—to develop applications for its Edison AI platform. These partnerships are expected to facilitate GE Healthcare's digital transformation by delivering advanced software solutions.  https://www.fatposglobal.com/reports/artificial-intelligence-in-the-cancer-market-842

2. Market Segmentation By Product Type  Targeted Therapy: Expected to grow at the highest CAGR during the forecast period, driven by the discovery of molecular targets in cancer cells. Advances in cellular technology and gene therapy have deepened our understanding of tumor biology, leading to the development of more effective, targeted treatments. By Cancer Type  Lung Cancer: While breast cancer currently holds a substantial market share due to its high prevalence, the lung cancer segment is anticipated to grow the fastest. The increasing global incidence of lung cancer and the need for early detection are key factors driving this growth. Market Dynamics Drivers 1.Expansion of Companies: Companies are expanding their geographical presence and introducing innovative solutions to address the shortage of radiologists, enable early disease detection, and maintain a competitive edge in the market. This includes partnerships, product launches, and strategic collaborations. Restraints 1.Reluctance to Adopt AI Technologies: Despite the advantages of AI in healthcare, there is resistance among medical professionals to adopt these technologies. Concerns include the fear that AI might replace physicians, as well as the belief that essential human qualities such as empathy cannot be replicated by machines. Additionally, there is apprehension that patients might overly rely on AI, potentially undermining the doctor-patient relationship. Inquiry Before Buying:https://www.fatposglobal.com/reports/artificial-intelligence-in-the-cancer- market-842 Key Players in the Market Prominent players in the AI in cancer market include:            Microsoft Corporation NVIDIA IBM Intel Siemens Healthineers GE Healthcare Digital Diagnostics Xilinx InformAI Enlitic Day Zero Diagnostics https://www.fatposglobal.com/reports/artificial-intelligence-in-the-cancer-market-842

3.     Aidence Butterfly Network, Inc. Prognos Zebra Medical Vision Regional Analysis The AI in cancer market is segmented across five major regions:  North America: Held the largest market share in 2020, driven by advanced healthcare infrastructure, significant R&D investments, and a high prevalence of cancer. Asia Pacific: Expected to grow at the fastest rate over the forecast period, fueled by emerging market strategies, improved medical diagnostics infrastructure, an aging population, and rising cancer rates.  About Us: An acronym for “Failures Are The Pillar of Success”, FATPOS Global has grown to become an end-to-end market intelligence firm. At FATPOS Global, we have emerged to become a reliable market research and management consulting company that caters to non-profits, corporations, and government agencies. Our aim is to help organizations make the right decisions backed by reliable data, in order to help them meet their growth goals. Industry research reports offered by the company are designed to offer quantifiable information integrated with key industry insights. FATPOS aims at extending necessary data with the main aim of ensuring sustainable organizational development. Innovation and value creation have always been at the forefront of our strategies. Our analysts are ace statisticians and well-versed in developing variable matrices and work with industry experts to extend accurate and rational solutions. Contact Us: Address: 74/1, Bindal Chowk, Paltan Bazaar, Dehradun, Uttarakhand 248001, India Contact No: +91 (135) 3501691 Email: info@fatposglobal.com Web: https://www.fatposglobal.com/ https://www.fatposglobal.com/reports/artificial-intelligence-in-the-cancer-market-842